<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03399019</url>
  </required_header>
  <id_info>
    <org_study_id>2016-I097</org_study_id>
    <nct_id>NCT03399019</nct_id>
  </id_info>
  <brief_title>Bispectral Index(BIS) on Depth of Sedation With Dexmedetomidine, Propofol and Midazolam During Spinal Anesthesia</brief_title>
  <acronym>BIS</acronym>
  <official_title>Usefulness of Bispectal Index (BIS) on Depth of Sedation With Dexmedetomidine, Propofol and Midazolam During Spinal Anesthesia : a Prospective Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hallym University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hallym University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to investigate on the objective relevance between bispectral index (BIS) and
      Observer's assessment of alertness/sedation (OAA/S) scale in patients sedated with Midazolam,
      propofol and dexmedetomidine during spinal anesthesia. Also, we will evaluate the reflection
      of actual sedation levels on BIS monitoring.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sedation is an important element of regional anesthesia during surgery, which allows to
      finish surgery smoothly by reducing patients' anxiety and fear who undergo regional and local
      anesthesia.

      If adequate sedation is not maintained during regional anesthesia, surgery may be disturbed
      by patient's movement. This can cause the patient to be physically and mentally stressed with
      discomfort.

      Commonly used measurement to determine the adequate sedation level relies on subjective
      physician's assessment such as scoring for response to talk, shake and pain. This measurement
      is unreliable and not continuous.

      Recently, BIS is used to guide sedation during spinal anesthesia as an objective monitoring
      method in many studies. but previous studies result contrasting in the correlation between
      BIS and sedation levels with lack in evaluation between sedative drugs.

      In this study, the investigators will investigate the usefullness of BIS monitoring during
      regional anesthesia with sedation and evaluate the suitability of correlation BIS and OAA/S
      between drugs (midazolam, propofol and dexmedetomidine). The anesthetic and sedation protocol
      will be standardized.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 5, 2016</start_date>
  <completion_date type="Anticipated">March 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This study compares to the same intervention (monitor BIS scores and OAA/S scores timely) between all of three sedative drugs.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>correlation between BIS and OAA/S (observer's assessment of alertness/sedation) score</measure>
    <time_frame>1 day</time_frame>
    <description>Statistically significant (p&lt;0.05) correlations between BIS (range of 0-100) and OAA/S scale (range of 1-5) in dexmedetomidine, propofol and midazolam.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The amount of rescue analgesics (fentanyl in mg) and rescue hypnotic (propofol in mg)</measure>
    <time_frame>1 day</time_frame>
    <description>The amount of rescue hypnotics due to insufficient sedation (total additional volume of propofol in mg) and rescue analgesics (total additional volume of fentanyl in mng) due to insufficient pain control</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Sedation</condition>
  <condition>Anesthesia, Spinal</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dexmedetomidine
: initial loading 0.5- 1 mng/kg for 10 minutes and maintenance 0.2-0.7mng/kg/hr
Check BIS (bispectral index) score and OAA/S (Observer assessment of alertness/sedation score) by time</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Propofol
: 0.75-3 mg/kr/hr continous infusion Check BIS (bispectral index) score and OAA/S (Observer assessment of alertness/sedation score) by time</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Midazolam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Midazolam
: initial loading 0.5- 1 mng/kg for 10 minutes and maintenance 0.2-0.7mng/kg/hr
Check BIS (bispectral index) score and OAA/S (Observer assessment of alertness/sedation score) by time</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>initial loading dose (0.5 ~ 1㎍/kg for 10 minutes) and maintenance infusion (0.2-0.7㎍/kg/hr)</description>
    <arm_group_label>Dexmedetomidine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>continuous infusion (0.75-3mg/kg/hr)</description>
    <arm_group_label>Propofol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>0.05mg/kg bolus injection and if not OAA/S ≤ 3 within 5 minutes, add 0.01mg/kg at intervals of 1~2 minutes</description>
    <arm_group_label>Midazolam</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who scheduled for knee arthroscopic surgery under spinal anesthesia

        Exclusion Criteria:

          -  Patients with a history of hepatic, renal, cardiovascular disease, and those who have
             allergy to study drugs (dexmedetomidine, propofol, midazolam).

          -  Hemodynamically unstable patients.

          -  Patients who is noncommunicative.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Soo Kyung Lee, M.D</last_name>
    <role>Study Director</role>
    <affiliation>Hallym University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yi Hwa Choi, M.D</last_name>
    <phone>+82-31-380-3945</phone>
    <email>pcyhchoi@hallym.or.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Soo Kyung Lee, M.D</last_name>
    <phone>+82-31-380-3945</phone>
    <email>agneta@hallym.or.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hallym University Sacred Heart Hospital</name>
      <address>
        <city>Anyang-si</city>
        <state>Gyeonggi-do</state>
        <zip>KS009</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Soo Kyung Lee, MD</last_name>
      <phone>+82-31-380-3944</phone>
      <phone_ext>3944</phone_ext>
      <email>agnetask@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Kato T, Koitabashi T, Ouchi T, Serita R. The utility of bispectral index monitoring for sedated patients treated with low-dose remifentanil. J Clin Monit Comput. 2012 Dec;26(6):459-63. doi: 10.1007/s10877-012-9379-4. Epub 2012 Jul 25.</citation>
    <PMID>22828857</PMID>
  </reference>
  <reference>
    <citation>Venn RM, Grounds RM. Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. Br J Anaesth. 2001 Nov;87(5):684-90.</citation>
    <PMID>11878517</PMID>
  </reference>
  <reference>
    <citation>Kasuya Y, Govinda R, Rauch S, Mascha EJ, Sessler DI, Turan A. The correlation between bispectral index and observational sedation scale in volunteers sedated with dexmedetomidine and propofol. Anesth Analg. 2009 Dec;109(6):1811-5. doi: 10.1213/ANE.0b013e3181c04e58.</citation>
    <PMID>19923507</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 2, 2017</study_first_submitted>
  <study_first_submitted_qc>January 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 16, 2018</study_first_posted>
  <last_update_submitted>January 7, 2018</last_update_submitted>
  <last_update_submitted_qc>January 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bispectral index monitor</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Midazolam</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

